Eating large amounts of oily, spicy, fried, or sugary foods while using GLP-1 medicines may worsen nausea, bloating, reflux, vomiting, or stomach discomfort.[8] How people eat becomes just as important as what they eat
Fasting glucose, insulin levels, glycated hemoglobin, and lipid profiles all improved significantly across dose groups
Potential long-term risks such as pancreatitis, gallbladder disease, and lean muscle mass loss are still being evaluated in ongoing Phase 3 trials
They represent two regulatory pathways for compounding under federal law
10.2337/diabetes.55.03.06.db05-0453 27 CoxF